Skip to content
Visit us at
www.anandandanand.com
Search
PATENTS REWIND : AN ANAND AND ANAND BLOG
Category:
Pharmaceuticals
Delhi High Court Grants Ex Parte Injunction Against Intas in Novartis’ Quia Timet Action Over Dabrafenib Patent
Delhi High Court Clarifies that Sequential Administration Does Not Render a Pharmaceutical Combination a “Method of Treatment”
Delhi High Court Reiterates that Composition Claims Cannot Be Recast as Treatment Claims Without Clear Justification
Salt on the Wound: Delhi High Court Affirms Broader Scope of ‘Comprising’ in Patent Claims
Stockpiling, Bolar Exemption, and Patent Infringement in E.R. Squibb vs Zydus
Macleods Pharmaceuticals Limited injuncted from manufacturing Linagliptin in any from
Review of the Intellectual Property Rights Regime in India by the standing committee on commerce
The order revoking Pharmacyclics LLC’s patent covering IBRUTINIB, set aside by the IPAB
Filing of additional documents, data and evidence in support of the invention is allowed under the Patent Law
Importance of Opposition Board and Opposition Board recommendation reinstated by the IPAB
Next Page
Subscribe
Subscribed
Patents Rewind - An Anand and Anand Blog
Join 107 other subscribers
Sign me up
Have a WordPress.com account?
Log in now.
Patents Rewind - An Anand and Anand Blog
View site in Reader
Manage subscriptions
Sign up
Log in
Report this content
Collapse this bar
